Table 3. Multivariate Analysis of the Risk Factors for Recurrence or Aggravation.
| Risk factor | OR | 95% CI | P-value |
|---|---|---|---|
| IFX or ADA | 6.0 | 0.855–42.470 | 0.530 |
| Fistula classification | 2.9 | 0.365–24.493 | 0.290 |
| Seton | 17.2 | 1.463–202.232 | 0.007 |
Logistic regression.
IFX, infliximab; ADA, adalimumab.